🚀 VC round data is live in beta, check it out!
Abbott India Valuation Multiples
Discover revenue and EBITDA valuation multiples for Abbott India and similar public comparables like Snibe, NewMarket, Chongqing Zhifei, Bruker and more.
Abbott India Overview
About Abbott India
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
Founded
1944
HQ
Employees
3.7K
Website
Financials (LTM)
EV
$6B
Abbott India Financials
Abbott India reported last 12-month revenue of $733M and EBITDA of $201M.
In the same LTM period, Abbott India generated $342M in gross profit, $201M in EBITDA, and $164M in net income.
Revenue (LTM)
Abbott India P&L
In the most recent fiscal year, Abbott India reported revenue of $747M and EBITDA of $208M.
Abbott India expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $733M | XXX | $747M | XXX | XXX | XXX |
| Gross Profit | $342M | XXX | $305M | XXX | XXX | XXX |
| Gross Margin | 47% | XXX | 41% | XXX | XXX | XXX |
| EBITDA | $201M | XXX | $208M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 28% | XXX | XXX | XXX |
| EBIT Margin | 28% | XXX | 27% | XXX | XXX | XXX |
| Net Profit | $164M | XXX | $165M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 22% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Abbott India Stock Performance
Abbott India has current market cap of $6B, and enterprise value of $6B.
Market Cap Evolution
Abbott India's stock price is $278.44.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $6B | -0.6% | XXX | XXX | XXX | $7.78 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAbbott India Valuation Multiples
Abbott India trades at 7.8x EV/Revenue multiple, and 28.4x EV/EBITDA.
EV / Revenue (LTM)
Abbott India Financial Valuation Multiples
As of March 29, 2026, Abbott India has market cap of $6B and EV of $6B.
Equity research analysts estimate Abbott India's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Abbott India has a P/E ratio of 36.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV (current) | $6B | XXX | $6B | XXX | XXX | XXX |
| EV/Revenue | 7.8x | XXX | 7.6x | XXX | XXX | XXX |
| EV/EBITDA | 28.4x | XXX | 27.4x | XXX | XXX | XXX |
| EV/EBIT | 28.0x | XXX | 28.4x | XXX | XXX | XXX |
| EV/Gross Profit | 16.6x | XXX | 18.6x | XXX | XXX | XXX |
| P/E | 36.1x | XXX | 35.8x | XXX | XXX | XXX |
| EV/FCF | 56.6x | XXX | 56.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Abbott India Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Abbott India Margins & Growth Rates
Abbott India's revenue in the last 12 month grew by 9%.
Abbott India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Abbott India's rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Abbott India's rule of X is 50% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Abbott India Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | (2%) | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | (3%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 37% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 50% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Abbott India Public Comps
See public comps and valuation multiples for other Biopharmaceuticals and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Snibe | XXX | XXX | XXX | XXX | XXX | XXX |
| NewMarket | XXX | XXX | XXX | XXX | XXX | XXX |
| Chongqing Zhifei | XXX | XXX | XXX | XXX | XXX | XXX |
| Bruker | XXX | XXX | XXX | XXX | XXX | XXX |
| Shanghai RAAS | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Abbott India M&A Activity
Abbott India acquired XXX companies to date.
Last acquisition by Abbott India was on XXXXXXXX, XXXXX. Abbott India acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Abbott India
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAbbott India Investment Activity
Abbott India invested in XXX companies to date.
Abbott India made its latest investment on XXXXXXXX, XXXXX. Abbott India invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Abbott India
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Abbott India
| When was Abbott India founded? | Abbott India was founded in 1944. |
| Where is Abbott India headquartered? | Abbott India is headquartered in India. |
| How many employees does Abbott India have? | As of today, Abbott India has over 3K employees. |
| Is Abbott India publicly listed? | Yes, Abbott India is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Abbott India? | Abbott India trades under ABBOTINDIA ticker. |
| When did Abbott India go public? | Abbott India went public in 2010. |
| Who are competitors of Abbott India? | Abbott India main competitors are Snibe, NewMarket, Chongqing Zhifei, Bruker. |
| What is the current market cap of Abbott India? | Abbott India's current market cap is $6B. |
| What is the current revenue of Abbott India? | Abbott India's last 12 months revenue is $733M. |
| What is the current revenue growth of Abbott India? | Abbott India revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Abbott India? | Current revenue multiple of Abbott India is 7.8x. |
| Is Abbott India profitable? | Yes, Abbott India is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Abbott India? | Abbott India's last 12 months EBITDA is $201M. |
| What is Abbott India's EBITDA margin? | Abbott India's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Abbott India? | Current EBITDA multiple of Abbott India is 28.4x. |
| What is the current FCF of Abbott India? | Abbott India's last 12 months FCF is $101M. |
| What is Abbott India's FCF margin? | Abbott India's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Abbott India? | Current FCF multiple of Abbott India is 56.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.